TP53 and breast carcinoma: Supporting a potential cooperation between YAP1 overexpression and p53-loss, we found that higher YAP1 expression is only associated with a worse outcome in human breast cancer cases with TP53 mutations (marginally), but not in those with WT TP53 or in BLBCs (Supplementary Fig. 3).